Clinical Trials Logo

Clinical Trial Summary

Dexmedetomidine is an α-2 adrenoreceptor agonist and has been extensively used through intravenous infusion,in order to improved the quality of block in regional anesthesia. In this prospective, randomized study, the authors focus on the effect of dexmedetomidine mixed with ropivacaine in coracoid approach brachial plexus block.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02961361
Study type Interventional
Source The First Hospital of Qinhuangdao
Contact
Status Completed
Phase Phase 4
Start date November 12, 2016
Completion date May 25, 2017